NINGBO INNO PHARMCHEM CO.,LTD. is proud to highlight the critical role of specialized chemical intermediates in the development and manufacturing of life-saving medications. Among these, (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one, identified by its CAS number 446292-10-0, stands out as a cornerstone in the synthesis of Rivaroxaban. Rivaroxaban is a vital direct factor Xa inhibitor, widely prescribed for the prevention and treatment of various thromboembolic disorders, including deep vein thrombosis, pulmonary embolism, and stroke prevention in patients with atrial fibrillation. The consistent and high-quality supply of its intermediates is paramount to ensuring the accessibility and efficacy of this critical drug.
The journey from raw materials to a finished pharmaceutical product is complex, with chemical intermediates acting as essential building blocks. (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one, with its precise molecular structure and purity, is indispensable for constructing the final Rivaroxaban molecule. Its availability and quality directly influence the efficiency of the synthesis process, the purity profile of the active pharmaceutical ingredient (API), and ultimately, the safety and effectiveness of the medication for patients worldwide. Understanding the pharmaceutical intermediates for anticoagulants is key for anyone involved in drug manufacturing and development.
At NINGBO INNO PHARMCHEM CO.,LTD., we are committed to providing chemical intermediates that meet the most stringent quality standards. Our focus on detailed chemical properties of rivaroxaban impurity ensures that our products contribute positively to the overall quality control of the final drug. For companies looking to buy 446292-10-0 CAS, reliability and adherence to specifications are non-negotiable. We understand the critical nature of these compounds and strive to be a trusted partner in the pharmaceutical supply chain.
The uses of (S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one extend beyond mere synthesis. It often serves as a reference standard in analytical studies, aiding in the identification and quantification of potential impurities. This is crucial for regulatory submissions, such as Abbreviated New Drug Application (ANDA) and Drug Master File (DMF) filings. The demand for high-quality pharmaceutical grade chemical intermediates like this one continues to grow as the global need for effective anticoagulants increases. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting this demand with exceptional products and services, facilitating the advancement of healthcare through chemistry.
Choosing the right supplier for critical intermediates is a strategic decision. When considering the rivaroxaban aminomethyl impurity price and its overall value, it is essential to look beyond cost alone and focus on quality, reliability, and the supplier's commitment to pharmaceutical standards. NINGBO INNO PHARMCHEM CO.,LTD. aims to be that partner, providing the essential building blocks that contribute to healthier lives.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.